Drugs / TETRAVAC-ACELLULAIRE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01546909 | Feb → Dec 2012 | diphtheria, poliomyelitis, tetanus | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TETRAVAC-ACELLULAIRE | “1 dose of TETRAVAC-ACELLULAIRE (0.5 mL) at Day 0” NCT01546909 ↗ |
| Modality | Vaccine | “Diphtheria, tetanus, polio and pertussis vaccination” NCT01546909 ↗ |